Work

Phase II clinical trial of imatinib mesylate in therapy of KIT and/or PDGFRalpha-expressing Ewing sarcoma family of tumors and desmoplastic small round cell tumors.

FWCI: 2.128
Cites: 24
Cited by: 55
Related to: 10